ROTHBLATT MARTINE A bought UTHR
March 19, 2026 · Form 4 insider transaction
ROTHBLATT MARTINE A bought 9,500 shares of United Therapeutics Corporation at $146.03 per share, a transaction worth $1.39M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
9,500
Price
$146.03
Total value
$1.39M
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 19, 2026
Filing dateMarch 20, 2026
Shares owned after50,013
OwnershipDirect
10b5-1 planNo
AmendedNo